A hot plate Ugo Basile, Italy, Model 7280 kept at 5456 C was used herein, on which the rats were placed
In light of the narrow therapeutic window defined by the balance between glucose-lowering efficacy and (so-called) gastrointestinal side effects, it seems unlikely that future long-acting GLP-1 receptor agonists will provide substantially greater efficacy without inducing more side effects compared with the already available compounds
Wegovy acts on the GLP-1 receptor to help control appetite, while Mounjaro targets both the GLP-1 and GIP receptors, which may enhance its effect in some patients
It reduces oxidative stress by inhibiting cytochrome C oxidase, the final enzyme in the electron transport chain connected to membrane potential of mitochondria
For patients beginning compounded tirzepatide therapy, understanding storage requirements is a foundational part of treatment adherence and safety